Neurava Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 23

Neurava General Information

Description

Developer of an artificial intelligence-powered wearable platform designed to track physiological indicators associated with sudden unexpected death in epilepsy and support management of epilepsy-related risks. The company offers multi-parameter neurological and cardiovascular monitoring, data synchronization, and timely notifications, enabling individuals with early and drug-resistant epilepsy, caregivers, and clinicians to take preventative measures, identify high-risk patterns, and support daily care.

Contact Information

Website
www.neurava.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 101 West Dickman Street
  • Suite 807
  • Baltimore, MD 21230
  • United States
+1 (904)
Primary Industry
Other Devices and Supplies
Other Industries
Diagnostic Equipment
Monitoring Equipment
Medical Supplies
Vertical(s)
Digital Health, Wearables & Quantified Self, Artificial Intelligence & Machine Learning, HealthTech, Mobile
Corporate Office
  • 101 West Dickman Street
  • Suite 807
  • Baltimore, MD 21230
  • United States
+1 (904)

Neurava Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurava Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC 14-Jul-2026 Completed Clinical Trials - General
12. Grant 23-Apr-2026 Completed Clinical Trials - General
11. Seed Round 16-Oct-2025 Completed Clinical Trials - General
10. Accelerator/Incubator Completed Clinical Trials - General
9. Seed Round 03-Apr-2024 Completed Clinical Trials - General
8. Seed Round 24-Aug-2023 Completed Clinical Trials - General
7. Accelerator/Incubator 01-Aug-2023 Completed Clinical Trials - General
6. Accelerator/Incubator Completed Clinical Trials - General
5. Accelerator/Incubator 01-Jun-2023 $25K $685K Completed Clinical Trials - General
4. Accelerator/Incubator 01-Nov-2021 $660K Completed Clinical Trials - General
To view Neurava’s complete valuation and funding history, request access »

Neurava Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed Plus
Seed-3
Seed-2 1,463,493 $0.000010 $0.5 $0.5 1x $0.5 10.42%
Seed-1 3,313,383 $0.000010 $0.68 $0.68 1x $0.68 23.59%
To view Neurava’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Neurava Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

Neurava Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4611623-A1 Device for monitoring sudden unexpected death in epilepsy Pending 01-Nov-2022
EP-4611623-A4 Device for monitoring sudden unexpected death in epilepsy Pending 01-Nov-2022
US-20260314992-A1 Device for monitoring sudden unexpected death in epilepsy Pending 01-Nov-2022
WO-2024097210-A1 Device for monitoring sudden unexpected death in epilepsy Inactive 01-Nov-2022
WO-2024097210-A9 Device for monitoring sudden unexpected death in epilepsy Inactive 01-Nov-2022 A61B5/0205
To view Neurava’s complete patent history, request access »

Neurava Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neurava Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds
TEDCO Venture Capital Minority
NIH Blueprint for Neuroscience Research Government
Ecphora Capital Venture Capital Minority
Sugati Ventures Venture Capital Minority
Symbiotic Ventures Venture Capital Minority
You’re viewing 5 of 23 investors. Get the full list »

Ready to get started?

Request a free trial

Neurava FAQs

  • When was Neurava founded?

    Neurava was founded in 2019.

  • Where is Neurava headquartered?

    Neurava is headquartered in Baltimore, MD.

  • What is the size of Neurava?

    Neurava has 8 total employees.

  • What industry is Neurava in?

    Neurava’s primary industry is Other Devices and Supplies.

  • Is Neurava a private or public company?

    Neurava is a Private company.

  • What is Neurava’s current revenue?

    The current revenue for Neurava is .

  • How much funding has Neurava raised over time?

    Neurava has raised $6.49M.

  • Who are Neurava’s investors?

    TEDCO, NIH Blueprint for Neuroscience Research, Ecphora Capital, Sugati Ventures, and Symbiotic Ventures are 5 of 23 investors who have invested in Neurava.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process